Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks
| Autor: | Ruby Palmer, Benjamin Crocker, Marianne Mcmanus, Rodolfo Usigli, Dennis J. Munjack, Anicia Zulueta, Michele Leonard, Diane E. Mcdowell, Richard A. Brown, Dennis D. Cabe |
|---|---|
| Rok vydání: | 1989 |
| Předmět: |
Adult
Male medicine.medical_specialty Adolescent Neurosis Placebo behavioral disciplines and activities Double-Blind Method Rating scale mental disorders medicine Humans Pharmacology (medical) Psychiatry Agoraphobia Clinical Trials as Topic Psychological Tests Alprazolam Panic disorder Panic Fear Middle Aged medicine.disease Propranolol humanities Psychiatry and Mental health Phobic Disorders Anxiety Female medicine.symptom Psychology medicine.drug |
| Zdroj: | Journal of clinical psychopharmacology. 9(1) |
| ISSN: | 0271-0749 |
| Popis: | Fifty-five patients completed a 5-week double-blind study comparing alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks. There was no concomitant behavioral treatment. Patient and therapist rating scales included Sheehan's Panic and Anxiety Attack Scales, the Marks-Sheehan Phobia Scale, the Hamilton Anxiety Scale, the Hamilton Depression Scale, and the Side Effects Checklist. The results generally support the efficacy of alprazolam, but not propranolol, in the treatment of panic disorder and agoraphobia with panic attacks. The significance of the results are discussed, as well as a number of the unique aspects of our procedures and patient population. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|